Cytogen (XKRX:217330) Accounts Payable & Accrued Expense : ₩1,170 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cytogen Accounts Payable & Accrued Expense?

Cytogen's quarterly accounts payable & accrued expense increased from Dec. 2023 (₩943 Mil) to Mar. 2024 (₩970 Mil) and increased from Mar. 2024 (₩970 Mil) to Jun. 2024 (₩1,170 Mil).

Cytogen's annual accounts payable & accrued expense increased from Dec. 2021 (₩417 Mil) to Dec. 2022 (₩627 Mil) and increased from Dec. 2022 (₩627 Mil) to Dec. 2023 (₩943 Mil).

Cytogen Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cytogen's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytogen Accounts Payable & Accrued Expense Chart

Cytogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

410.96

387.21

417.35

627.10

942.64

Cytogen Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															663.21	1,061.38	942.64	970.22	1,170.30

Cytogen Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cytogen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cytogen Inc (XKRX:217330) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

128, Beobwon-ro, Songpa-gu, A-8 Floor, SK V1 GL Metrocity, Seoul, KOR, 05854

Website

http://www.cytogenlab.com

Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.

Cytogen Headlines

No Headlines